SCHEMBL3722944

SCHEMBL3722944

C[C@@H](Nc1nc(C(N)=O)cc(-c2ccc(Br)cc2)n1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 1/20 0.50
SCN9A Q15858 1/20 0.50
ALDH1A1 P00352 2/20 0.47
GRM2 Q14416 1/20 0.46
AGTR1 P30556 1/20 0.46
LDHB P07195 3/20 0.43
MCL1 Q07820 1/20 0.43
LDHA P00338 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CAMK2D Q13557 2/20 0.43
EGFR P00533 1/20 0.43
LMNA P02545 1/20 0.42
HDAC3 O15379 3/20 0.42
HDAC1 Q13547 3/20 0.42
HDAC2 Q92769 3/20 0.42
HDAC6 Q9UBN7 3/20 0.42
ADORA1 P30542 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3721092 0.86 SCN9A (0.50) FPR2SCN9ALDHBLDHA
SCHEMBL1733575 0.83 FPR2 (0.55) FPR2SCN9AALDH1A1AGTR1KDM4E
SCHEMBL3718054 0.78 GRM2 (0.46) FPR2SCN9AGRM2AGTR1MCL1
SCHEMBL1735244 0.75 FPR2 (0.50) FPR2SCN9AALDH1A1AGTR1KDM4E
SCHEMBL1735520 0.75 KDM4E (0.56) FPR2SCN9AALDH1A1KDM4ELMNA
SCHEMBL1735518 0.74 KDM4E (0.50) FPR2SCN9AALDH1A1KDM4ELMNA
SCHEMBL1733664 0.73 TDP1 (0.65) FPR2SCN9AALDH1A1AGTR1KDM4E
SCHEMBL3727320 0.73 SCN9A (0.43) FPR2SCN9AALDH1A1GRM2AGTR1
SCHEMBL6082153 0.73 MAPK14 (0.54) HDAC3HDAC1HDAC2HDAC6
SCHEMBL1733671 0.73 KDM4E (0.53) FPR2SCN9AALDH1A1AGTR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8614201-B2 Heterocyclic amides as modulators of TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2013-12-24 US disclosed
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO disclosed